Anti-angiogenic effect of the total flavonoids in Scutellaria barbata D. Don

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Dai, Zhi Jun ^a   Lu, Wang Feng ^a,b   Gao, Jie ^a   Kang, Hua Feng ^a   Ma, Yu Guang ^a   Zhang, Shu Qun ^a   Diao, Yan ^a   Lin, Shuai ^a   Wang, Xi Jing ^a   Wu, Wen Ying ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Shangluo Central Hospital   (China)

Author keywords

Angiogenesis; Hepatocellular Carcinoma; Human Umbilical Vein Endothelial Cells; Scutellaria Barbata

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; APIGENIN; BAICALEIN; LUTEOLIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHICK EMBRYO; CHORIOALLANTOIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SCUTELLARIA BARBATA; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INHIBITORS; ANIMALS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; FLAVONOIDS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; PLANT EXTRACTS; SCUTELLARIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84879491696     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-150     Document Type: Article

References (44)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Kim DY, Han KH. How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage. Dig Dis 2012, 30:598-602. 10.1159/000343088, 23258101.
3. Chang CY, Huang ZN, Yu HH, Chang LH, Li SL, Chen YP, Lee KY, Chuu JJ. The adjuvant effects of Antrodia Camphorata extracts combined with anti-tumor agents on multidrug resistant human hepatoma cells. J Ethnopharmacol 2008, 118:387-395. 10.1016/j.jep.2008.05.001, 18571350.
4. Xu W, Towers AD, Li P, Collet JP. Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. Eur J Cancer Care 2006, 15:397-403.
5. Normile D. The new face of traditional Chinese medicine. Science 2003, 299:188-190. 10.1126/science.299.5604.188, 12522228.
6. Parekh HS, Liu G, Wei MQ. A new dawn for the use of traditional Chinese medicine in cancer therapy. Mol Cancer 2009, 8:21. 10.1186/1476-4598-8-21, 2664781, 19298677.
7. Mineo M, Garfield SH, Taverna S, Flugy A, DeLeo G, Alessandro R, Kohn EC. Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis 2012, 15:33-45. 10.1007/s10456-011-9241-1, 3595015, 22203239.
8. Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vasc Health Risk Manag 2006, 2:213-219. 10.2147/vhrm.2006.2.3.213, 1993983, 17326328.
9. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257. 10.1038/35025220, 11001068.
10. Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscl Throm Vas 2005, 25:1545-1550.
11. Wojtukiewicz MZ, Sierko E, Rak J. Contribution of the hemostatic system to angiogenesis in cancer. Semin Thromb Hemost 2004, 30:5-20.
12. Li JL, Sainson RCA, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, Harris AL. Delta-like 4 notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth In vivo. Cancer Res 2007, 67:11244-11253. 10.1158/0008-5472.CAN-07-0969, 18056450.
13. Roodink I, Leenders WPJ. Targeted therapies of cancer angiogenesis inhibition seems not enough. Cancer Lett 2010, 299:1-10. 10.1016/j.canlet.2010.09.004, 20889254.
14. Kim KW, Jin UH, Kim DI, Lee TK, Kim MS, Oh MJ, Kim MS, Kwon DY, Lee YC, Kim CH. Antiproliferative effect of Scutellaria barbata D. Don. on cultured human uterine leiomyoma cells by down-regulation of the expression of Bcl-2 protein. Phytother Res 2008, 22:583-590. 10.1002/ptr.1996, 18444248.
15. Tang PM, Chan JY, Zhang DM, Au SWN, Fong WP, Kong SK, Tsui SKW, Waye MMY, Mak TCW, Fung KP. Pheophorbide a, an active component in Scutellaria barbata, reverses P-glycoprotein-mediated multidrug resistance on a human hepatoma cell line R-HepG2. Cancer Biol Ther 2007, 6:504-509. 10.4161/cbt.6.4.3814, 17457045.
16. Goh D, Lee YH, Ong ES. Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem 2005, 53:8197-8204. 10.1021/jf051506+, 16218664.
17. Yin X, Zhou J, Jie C, Xing DM, Zhang Y. Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci 2004, 75:2233-2244. 10.1016/j.lfs.2004.05.015, 15325848.
18. Suh SJ, Yoon JW, Lee TK, Jin UH, Kim SL, Kim MS, Kwon DY, Lee YC, Kim CH. Chemoprevention of Scutellaria bardata on human cancer cells and tumorigenesis in skin cancer. Phytother Res 2007, 21:135-141. 10.1002/ptr.2010, 17128438.
19. Dai ZJ, Gao J, Li ZF, Ji ZZ, Kang HF, Guan HT, Diao Y, Wang BF, Wang XJ. In vitro and In vivo antitumor activity of Scutellaria barbate extract on murine liver cancer. Molecules 2011, 16:4389-4400. 10.3390/molecules16064389, 21623310.
20. Yu JQ, Liu HB, Lei JC, Tan WJ, Hu XT, Zou GL. Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res 2007, 21:817-822. 10.1002/ptr.2062, 17674423.
21. Qu GW, Yue XD, Li GS, Yu QY, Dai SJ. Two new cytotoxic ent-clerodane diterpenoids from Scutellaria barbata. J Asian Nat Prod Res 2010, 12:859-864. 10.1080/10286020.2010.507546, 20924899.
22. Dai SJ, Sun JY, Ren Y, Liu K, Shen L. Bioactive ent-clerodane diterpenoids from Scutellaria barbata. Planta Med 2007, 73:1217-1220. 10.1055/s-2007-990215, 17764068.
23. Mi X, Zhu R. Simultaneous determination of 7 active ingredients in Scutellaria barbata D. Don by capillary micellar electrokinetic chromatography. Se Pu 2010, 28:209-214.
24. Dai SJ, Peng WB, Shen L, Zhang DW, Ren Y. New norditerpenoid alkaloids from Scutellaria barbata with cytotoxic activities. Nat Prod Res 2011, 15:1-6.
25. Wang XL, Zhang N, Huo Q, Yang Q. Anti-angiogenic and antitumor activities of Huaier aqueous extract. Oncol Rep 2012, 28:1167-1175. 3583466, 22895629.
26. Yeh JC, Cindrova-Davies T, Belleri M, Morbidelli L, Miller N, Cho CW, Chan K, Wang YT, Luo GA, Ziche M, Presta M, Charnock-Jones DS, Fan TP. The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo. Angiogenesis 2011, 14:187-197. 10.1007/s10456-011-9202-8, 21327473.
27. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008, 358:2039-2049. 10.1056/NEJMra0706596, 18463380.
28. Borges J, Tegtmeier FT, Padron NT, Mueller MC, Lang EM, Stark GB. Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Eng 2003, 9:441-450. 10.1089/107632703322066624, 12857412.
29. Hagedorn M, Balke M, Schmidt A, Bloch W, Kurz H, Javerzat S, Rousseau B, Wilting J, Bikfalvi A. VEGF coordinates interaction of pericytes and endothelial cells during vasculogen-esis and experimental angiogenesis. Dev Dyn 2004, 230:23-33. 10.1002/dvdy.20020, 15108306.
30. Kilarski WW, Petersson L, Fuchs PF, Zielinski MS, Gerwins P. An in vivo neovascularization assay for screening regulators of angiogenesis and assessing their effects on pre-existing vessels. Angiogenesis 2012, 15:643-655. 3496524, 22918697.
31. Yu JL, Rak JW. Host microenvironment in breast cancer development Inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res 2003, 5:83-88. 10.1186/bcr573, 154151, 12631386.
32. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999, 77:527-543. 10.1007/s001099900019, 10494799.
33. Delli-Carpini J, Karam AK, Montgomery L. Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis 2010, 13:43-58. 10.1007/s10456-010-9163-3, 20229258.
34. Marconett CN, Morgenstern TJ, San Roman AK, Sundar SN, Singhal AK, Firestone GL. BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype. Cancer Bio Ther 2010, 10:397-405.
35. Shiau AL, Shen YT, Hsieh JL, Wu CL, Lee CH. Scutellaria barbata inhibits angiogenesis through downregulation of HIF-1 α in lung tumor. Environ Toxicol 2012,
36. Wei LH, Lin JM, Xu W, Hong ZF, Liu XX, Peng J. Inhibition of tumor angiogenesis by Scutellaria barbata D. Don via suppressing proliferation, migration and tube formation of endothelial cells and downregulation of the expression of VEGF-A in cancer cells. J Med Plants Res 2011, 5:3260-3268.
37. Lee TK, Kim DI, Song YL, Lee YC, Kim HM, Kim CH. Differential inhibition of Scutellaria barbata D. Don (Lamiaceae) on HCG-promoted proliferation of cultured uterine leiomyomal and myometrial smooth muscle cells. Immunopharmacol Immunotoxicol 2004, 26:329-342. 10.1081/IPH-200026841, 15518168.
38. Su JL, Yang PC, Shih JY, Yang CY, Wei LH, Hsieh CY, Chou CH, Jeng YM, Wang MY, Chang KJ, Hung MC, Kuo ML. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 2006, 9:209-223. 10.1016/j.ccr.2006.02.018, 16530705.
39. Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D, Schactman M, Shapiro CL. A phase IB dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat 2010, 120:111-118. 10.1007/s10549-009-0678-5, 20054647.
40. Wei LH, Lin JM, Xu W, Cai Q, Shen A, Hong Z, Peng J. Scutellaria barbata D. Don inhibits tumor angiogenesis via suppression of hedgehog pathway in a mouse model of colorectal cancer. Int J Mol Sci 2012, 13:9419-9430. 10.3390/ijms13089419, 3431803, 22949805.
41. Viana CT, Campos PP, Carvalho LA, Cenedezi JM, Lavall L, Lopes MT, Ferreira MA, Andrade SP. Distinct types of tumors exhibit differential grade of inflammation and angiogenesis in mice. Microvasc Res 2012, 86:44-51.
42. Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 2008, 99:1501-1506. 10.1111/j.1349-7006.2008.00853.x, 18754859.
43. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metast Rev 2006, 25:315-322.
44. Soker S, Kaefer M, Johnson M, Klagsbrun M, Atala A, Freeman MR. Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. Am J Pathol 2001, 159:651-659. 10.1016/S0002-9440(10)61736-1, 1850559, 11485923.